News Stories

 

Technology Commercialization Proof-of -Concept Grants Available

Technology Commercialization Proof-of -Concept Grants Available

Public Impact Research Initiative Grants Available

Public Impact Research Initiative Grants Available

Glenn Yiu, an associate professor in the Department of Ophthalmology and Vision Science.

UC Davis Receives $3.2 Million Award to Study Age-Related Macular Degeneration

Glenn Yiu, an associate professor in the Department of Ophthalmology…
UC Davis Licenses Novel COVID-19 Lung Treatment Using Inhaled Statins to InVixa, Inc

UC Davis Licenses Novel COVID-19 Lung Treatment Using Inhaled Statins to InVixa, Inc

The University of California, Davis and InVixa Inc., a biopharmaceutical…
Update on COVID-19 Research Operations on Campus

Update on COVID-19 Research Operations on Campus

Campus leadership recently announced plans for a return to primarily…
iSeroSnFR was created by fusing a serotonin binding protein to a green fluorescent protein.

Innovative serotonin sensor to improve neurological drug development

(SACRAMENTO) — A research team led by UC Davis scientists used…
Mosquito on skin with green background.

Zika Virus Affects Eye Development Before But Not After Birth

By Lisa Howard While the SARS-CoV-2 virus has dominated the…
Girl participating in online education training class with teacher and other students using laptop at home. (iStock photo)

New Project Documents How California’s K-12 Schools are Tackling the Pandemic

By Lisa Howard Over the past 10 months, K-12 school districts…
Shasqi CEO José M. Mejía Oneto.

‘Click Chemistry’ Cancer Treatment Developed by UC Davis Startup Now in Clinical Trials

By Lisa Howard Shasqi, a startup enabled with technology developed…
Holiday Greetings from the Office of Research

Holiday Greetings from the Office of Research